• 1
    Vainio H, Bianchini F, eds. Handbooks of Cancer Prevention. Volume 7: Breast Cancer Screening. Lyon, France: IARC Press; 2002.
  • 2
    Gotzsche PC, Nielsen M. Screening for breast cancer with mammography [serial online]. Cochrane Database Syst Rev. 2011;(4):CD001877.
  • 3
    Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380:17781786.
  • 4
    Broeders M, Moss SM, Nystrom L, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen. 2012;19(suppl 1):1425.
  • 5
    Njor S, Nystrom L, Moss S, et al. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen. 2012;19(suppl 1):3341.
  • 6
    Freedman DA, Petitti DB, Robins JM. On the efficacy of screening for breast cancer. Int J Epidemiol. 2004;33:4355.
  • 7
    Olsen AH, Njor SH, Lynge E. Estimating the benefits of mammography screening: the impact of study design. Epidemiology. 2007;18:487492.
  • 8
    Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909919.
  • 9
    Kalager M, Zelen M, Langmark F, et al. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363:12031210.
  • 10
    van Ravesteyn NT, Heijnsdijk EA, de Koning HJ. More on screening mammography. N Engl J Med. 2011;364:282283.
  • 11
    Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:17841792.
  • 12
    Kalager M, Haldorsen T, Bretthauer M, et al. Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study [serial online]. Breast Cancer Res. 2009;11:R44.
  • 13
    Olsen AH, Lynge E, Njor SH, et al. Breast cancer mortality in Norway after the introduction of mammography screening. Int J Cancer. 2013;132:208214.
  • 14
    Hofvind S, Geller B, Vacek PM, et al. Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol. 2007;22:447455.
  • 15
    Perry N, Broeders M, Tornquist S, et al. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. Luxembourg: Official Publication of the European Communities; 2006.
  • 16
    Cancer Registry of Norway. Regulation on the collection and processing of personal health data in the Cancer Registry of Norway (Cancer Registry Regulations) [January 2013 update]. Oslo, Norway; Cancer Registry of Norway, 2001. Available at: www.ub.uio.ujur.ulovdata/for-20011221–1477-eng.doc. Accessed May 11, 2013.
  • 17
    Larsen IK, Smastuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45:12181231.
  • 18
    World Health Organization. International Statistical Classification of Diseases and Health-Related Problems. International Classification of Diseases, 10th Revision. Geneva, Switzerland: World Health Organization; 2007. Available at: Accessed May 11, 2013.
  • 19
    Alfsen GC, Maehlen J. The value of autopsies for determining the cause of death. Tidsskr Nor Laegeforen. 2012;132:147151.
  • 20
    Duffy SW, Cuzick J, Tabar L, et al. Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. Appl Stat. 2002;51(part 2):235243.
  • 21
    Roder D, Houssami N, Farshid G, et al. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat. 2008;108:409416.
  • 22
    Nystrom L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993;341:973978.
  • 23
    Paap E, Verbeek A, Puliti D, Broeders M, Paci E. Minor influence of self-selection bias on the effectiveness of breast cancer screening in case-control studies in the Netherlands. J Med Screen. 2011;18:142146.
  • 24
    Gabe R, Tryggvadottir L, Sigfusson BF, et al. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol. 2007;48:948955.
  • 25
    Puliti D, Miccinesi G, Collina N, et al. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer. 2008;99:423427.
  • 26
    Roth-Hoff S, Klepp O, Hofvind S. Asymptomatic breast cancer in non-participants of the national screening-program in Norway: a confounding factor in the evaluation of the program [published online ahead of print February 6, 2013]. J Med Screen. 2013.
  • 27
    Norsk Brystcancer Gruppe. Recommendations for treatment of women with ductal carcinoma in situ and breast cancer in Norway. Available at: Accessed May 11, 2013.
  • 28
    Baker SG, Kramer BS, Prorok PC. Statistical issues in randomized trials of cancer screening. BMC Med Res Methodol. 2002;19:1118.
  • 29
    Cuzick J, Edwards R, Segnan N. Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med. 1997;16:10171029.
  • 30
    Hofvind S. Breast cancer screening—prevalence of disease in women who only respond after an invitation reminder. J Med Screen. 2007;14:2122.